AAPL 186.2 -1 (-0.53%)MSFT 115.68 -1.29 (-1.10%)FB 166.03 -0.08 (-0.05%)ZNGA 5.37 -0.04 (-0.83%)NVDA 169.95 -0.19 (-0.11%)WBA 62.59 +0.41 (+0.66%)GOOG 1184.6 -10.72 (-0.90%)PIH 5.63 +1.49 (+35.99%)
AAPL 186.2 -1 (-0.53%)MSFT 115.68 -1.29 (-1.10%)FB 166.03 -0.08 (-0.05%)ZNGA 5.37 -0.04 (-0.83%)NVDA 169.95 -0.19 (-0.11%)WBA 62.59 +0.41 (+0.66%)GOOG 1184.6 -10.72 (-0.90%)PIH 5.63 +1.49 (+35.99%)

Discounted Cash Flow (DCF) Analysis Levered

KalVista Pharmaceuticals Inc. Quote

KalVista Pharma (KALV)

28.90 -0.03 Healthcare
All | Free Cash Flow | Weighted Average Cost Of Capital | Build Up Free Cash | Terminal Value | Intrinsic Value | Results |

Free Cash Flow KALV Quote KalVista Ph

Weighted Average Cost Of Capital KALV Quote KalVista Ph

Share Price $ 28.9
Diluted Shares Outstanding 1
Cost of Debt
Tax Rate -
After-tax Cost of Debt 5.0
Risk Free Rate
Market Risk Premium
Cost of Equity 22.06
Total Debt 0.00
Total Equity 289.00
Total Capital 289.00
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash Flow KALV Quote KalVista Ph

Terminal Value KALV Quote KalVista Ph

Growth in perpetuity method:
Long term growth rate
WACC (%) 22.1
Free cash flow (t+1) -NaN.N
Terminal Value -NaN.N
Present Value of Terminal Value -NaN.N

Intrinsic Value KALV Quote KalVista Ph

Enterprise Value -NaN
Net Debt -51
Equity Value -NaN
Shares Outstanding 10
Equity Value Per Share -NaN

Results Levered DCF KALV Quote KalVista Ph